RUCCI CAROLYN M. (SVP, Chief Legal Officer) sold 10.6% of their position (69.77K shares) of AKEBIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $97.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/4/2026ACC: 0002107264-26-000006
Officer· SVP, Chief Legal Officer
Since Feb 2026
-69.77K
Net shares
Net seller
$97.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
69.77K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−16.85K
Price / share
$1.39
Trade value
$23.42K
% of position
2.6%
2/2/2026
658.15K→641.30K
Common Stock
Direct
Shares
−25.38K
Price / share
$1.39
Trade value
$35.28K
% of position
4.0%
2/2/2026
641.30K→615.92K
Common Stock
Direct
Shares
−27.54K
Price / share
$1.39
Trade value
$38.29K
% of position
4.5%
2/2/2026
615.92K→588.38K
Total
Net shares
−69.77K
Net value
-$96.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −16.85K | $1.39 | $23.42K | 2.6% | 658.15K | 641.30K |
| Common Stock Direct | 2/2/2026 | S · Sale | −25.38K | $1.39 | $35.28K | 4.0% | 641.30K | 615.92K |
| Common Stock Direct | 2/2/2026 | S · Sale | −27.54K | $1.39 | $38.29K | 4.5% | 615.92K | 588.38K |
| Total | −69.77K | -$96.98K | ||||||
Derivative Transactions0
No derivative transactions reported